PP01.11: Clinical Outcomes of Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer Patients: A Retrospective Study from Bogotá

Andres Felipe BejaranoNicolás Duque ClavijoHenry VargasErick CantorJavier SegoviaLuís Pino2026-03-222026-03-22202510.1016/j.jtho.2025.07.063https://doi.org/10.1016/j.jtho.2025.07.063https://andeanlibrary.org/handle/123456789/77761enMedicineOsimertinibLung cancerOncologyRetrospective cohort studyMutantInternal medicineCancerPP01.11: Clinical Outcomes of Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer Patients: A Retrospective Study from Bogotáarticle